# Pomalidomide (Pomalidomide)

Source: https://ourhealthnetwork.com/drugs/pomalidomide
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Pomalidomide?

Pomalidomide is a thalidomide analog. It is prescribed to treat multiple myeloma. Across the United States, 2,000 doctors prescribe Pomalidomide to approximately 4,000 Medicare patients.

## Brand names

Pomalidomide

## Indications

Pomalidomide is primarily prescribed for the treatment of multiple myeloma.

## Conditions treated

- [Multiple Myeloma](https://ourhealthnetwork.com/conditions/multiple-myeloma)

## Mechanism of action

Pomalidomide is an analogue of thalidomide with immunomodulatory, antiangiogenic, and antineoplastic properties. Cellular activities of pomalidomide are mediated through its target cereblon, a component of a cullin ring E3 ubiquitin ligase enzyme complex.

## Drug classification

- Established Pharmacologic Class: Thalidomide Analog [EPC]
- Route of administration: ORAL

## Common side effects

anemia, back pain, constipation, d fatigue and asthenia, diarrhea, dyspnea, nausea, neutropenia

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)